The Predictive Value of On-treatment Virological Response for Sustained Virological Response in Chronic Hepatitis C

NCT01464008 · clinicaltrials.gov ↗

COMPLETED

Status

297

Enrollment

OTHER

Sponsor class

Conditions

Chronic Hepatitis C

Interventions

DRUG: Pegylated interferon alfa-2a and ribavirin

Sponsor

Beijing Ditan Hospital